Home › Markets › Basic Materials › KRO

Kronos Worldwide Inc (KRO)

KRO trades on NYSE in Basic Materials, Major Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$7.46
+0.13% on the day
Market cap
$858.6M
Small cap
Revenue · 2025
$1.9B
-1.5% on 2024
Net income · 2025
-$110.9M
-6.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerKRO on NYSE
SectorBasic Materials
IndustryMajor Chemicals
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001257640
SEC industry codeIndustrial Inorganic Chemicals

Financials · 2025

LineValue
Revenue$1.9B
Net income-$110.9M
Operating income-$36.5M
Net margin-6.0%
Operating margin-2.0%
Revenue growth-1.5%
Cash$33.2M
Total assets$1.8B
P/E (computed)Net income was not positive
P/S (computed)0.5×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
DEFINITIVE FINAL PROSPECTUS
424B42010-10-28
Latest annual report10-K2026-03-09
Latest quarterly / interim10-Q2026-08-05
Latest current report8-K2026-08-05
Latest proxyDEFA14A2026-03-24

Source: SEC EDGAR submissions feed, 1,005 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-5.9%
1 month-10.5%
3 months+9.6%
Year to date+65.6%
1 year+39.4%
From 52-week high-17.8%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Major Chemicals

TickerCompanyPriceDayMarket cap
FTKFlotek Industries Inc.$27.07+5.54%$980.5M
BAKBraskem SA ADR$1.87+5.06%$745.4M
WLKPWestlake Chemical Partners LP Common Units representing limited partner interests$21.10+0.10%$743.7M
LXULSB Industries Inc.$10.23+4.28%$736.5M
PCTPureCycle Technologies Inc.$3.44-4.44%$691.1M
GPREGreen Plains Inc.$15.58+6.71%$1.1B
ECVTEcovyst Inc.$10.08+1.61%$1.1B
FMCFMC Corporation$8.31-0.12%$1.3B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier